The EPO granted patent EP4082440A1 to Neuboron Therapy System Ltd. for a radiation irradiation system used in boron neutron capture therapy (BNCT). The patent covers therapeutic irradiation apparatus (A61B 6/04) and radiotherapeutic systems (A61N 5/10). Designated states include all 36 EPC contracting states spanning the EU, EFTA, and other European countries.

This is a standard patent publication notice with no compliance requirements or deadlines. Companies developing BNCT technology or radiation therapy systems should review the patent claims to assess potential freedom-to-operate implications for their own products. Neuboron Therapy System Ltd. now holds enforceable patent rights across European designated states.